Nausea · participants with generalised epilepsy
Summary of findings: catgut implantation at acupoints showed no clear difference in frequency of adverse effects ‐ nausea ( compared with valproate (low certainty).
1 finding from 1 review
Nausea · participants with generalised epilepsy
Summary of findings: needle acupuncture plus valproate showed no clear difference in frequency of adverse effects ‐ nausea ( compared with valproate alone (low certainty).
1 finding from 1 review
Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia
It is very uncertain whether COMPARISON 1. ARIPIPRAZOLE changes adverse effects: extrapyramidal effects compared with CLOZAPINE (very low certainty).
1 finding from 1 review
Adverse effects: 1. Death ‐ medium term · patients with schizophrenia
1 finding from 1 review
Adverse effects/events: at least 1 adverse effect ‐ as defined by individual studies. · adults with pressure ulcers
It is very uncertain whether summary of findings table ‐ Collagen changes side effects: at least one adverse event compared with standard diet or placebo (very low certainty).
1 finding from 1 review
Adverse effects (central nervous system) · participants with epilepsy (BECTS)
Sulthiame showed no clear difference in adverse effects (central nervous system) compared with levetiracetam (low certainty).
1 finding from 1 review
Adverse effects (participant interviews) · adults and children with cystic fibrosis
1 finding from 1 review
Adverse effects: ANCA positive/arthritis · SSNS in children
Levamisole showed no clear difference in adverse effects: ANCA positive/arthritis compared with steroids or placebo or both, or no treatment (low certainty).
1 finding from 1 review
Adverse effects for the infant or mother · increasing breast milk production in mothers of non‐hospitalised term infants
1 finding from 1 review
WDAEs · people with primary hypertension
Renin inhibitors showed no clear difference in withdrawal due to adverse effects (WDAE) compared with ACE inhibitors (low certainty).
1 finding from 1 review
Adverse effects associated with hormones · women with endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: Systolic blood pressure · patients of all ages with oedema due to nephrotic syndrome
1 finding from 1 review
Adverse effects: warmth at infusion site · people with sickle cell disease
Intravenous magnesium sulphate may leads to higher adverse effects: warmth at infusion site compared with placebo (low certainty).
1 finding from 1 review
Adverse effects to dietary modifications · infants with colic defined by recognised criteria
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Adverse effects: vomiting 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: vomiting 48 to 72 hours (low certainty).
1 finding from 1 review
Potential adverse effects ‐ not reported · patients with drug‐resistant epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Major adverse effects ‐ Thrombocytopenia · people with non‐transfusion dependent beta thalassaemia
It is very uncertain whether the intervention changes major adverse effects ‐ Thrombocytopenia (very low certainty).
1 finding from 1 review
Adverse effects/events ‐ extrapyramidal symptoms ‐ medium term Number of instances of extrapyramidal symptoms · patients with schizophrenia
It is very uncertain whether FLUPHENAZINE DECANOATE changes extrapyramidal adverse effects ‐ general compared with ORAL NEUROLEPTICS (very low certainty).
1 finding from 1 review
Adverse effects/events ‐ extrapyramidal symptoms ‐ medium term Number of instances of extrapyramidal symptoms · patients with schizophrenia
It is very uncertain whether FLUPHENAZINE DECANAOTE changes extrapyramidal adverse effects ‐ general compared with FLUPHENAZINE ENANTHATE (very low certainty).
1 finding from 1 review
Adverse effects: Leaving the study early · patients with schizophrenia
It is very uncertain whether TEMPOROPARIETAL TMS changes adverse effects: Leaving the study early compared with STANDARD TREATMENT (very low certainty).
1 finding from 1 review